Quantcast

Latest Adalimumab Stories

2012-06-01 08:59:44

Education is key to success; functional disability negatively impacts job performance As children with juvenile idiopathic arthritis (JIA) grow into adulthood, disability due to disease may adversely affect their ability to achieve educational success. Findings published in Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR), suggest that functional disability impacts educational attainment, which is key to successful employment in adulthood. Arthritis is...

2012-05-31 23:00:20

"Ankylosing spondylitis is now being treated with regenerative medicine at he center for regenerative medicine." according to A.J. Farshchian MD an orthopedic regenerative practitioner at the center for regenerative medicine. Miami, Florida (PRWEB) May 30, 2012 "Ankylosing spondylitis is now being treated with regenerative medicine at he center for regenerative medicine." according to A.J. Farshchian MD an orthopedic regenerative practitioner at the center for regenerative medicine....

Advisory Panel Recommends FDA Approval Of Rheumatoid Arthritis Drug
2012-05-11 05:46:04

Connie K. Ho for RedOrbit.com An advisory panel recommends that the U.S. Food and Drug Administration (FDA) consider approving Pfizer´s pill to treat rheumatoid arthritis. The pill, tofacitinib, would be sold to patients who don´t respond to traditional rheumatoid arthritis treatments. On May 9, the panel of outside experts voted 8-2 to recommend the drug for approval. However, the agency doesn´t necessarily need to follow the panel´s advice. Tofacitinib is one of...

2012-04-23 20:20:01

Tokyo, Apr 23, 2012 - (JCN Newswire) - Abbott Japan Co., Ltd. and Eisai Co., Ltd. announced today that they have received notification from Japan's Ministry of Health, Labour and Welfare (MHLW) that the condition for approval of Humira(R) pre-filled syringe 40 mg/0.8 mL for subcutaneous injection (adalimumab [genetical recombination]), a fully human anti-TNF-alpha monoclonal antibody, has been lifted in terms of a drug use results survey (all-case surveillance) for plaque psoriasis and...

2012-04-03 10:06:28

The American College of Rheumatology (ACR) has released the 2012 recommendations for the use of disease-modifying antirheumatic drugs (DMARDs) and biologic agents in the treatment of rheumatoid arthritis (RA). The guidelines published today in the ACR journal, Arthritis Care & Research, are an update to the 2008 recommendations and address the issues of initiating and switching drugs, screening for tuberculosis (TB) reactivation, immunization, and the use of biologics in high-risk RA...

2012-03-17 00:02:02

A clinical study co-led by the Montreal Heart Institute and Innovaderm Research Inc., which was presented today at the annual meeting of the American Academy of Dermatology, shows that a new treatment for psoriasis could be associated with a significant decrease in vascular inflammation, a major risk factor of cardiovascular disease. Psoriasis is a chronic inflammatory disease of the skin and joints that affects up to 3% of the population. This disease is associated with a greater risk of...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'